Back to search
Patients With Schizophrenia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Patients With Schizophrenia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Patients With Schizophrenia trials you may qualify forThis study will evaluate the efficacy of valbenazine on clinician- and patient-reported outcomes in participants with TD while receiving or after stopping a VMA…
This is a Phase 3, randomized, double blind, placebo controlled, fixed dose, study designed to evaluate the efficacy, safety, tolerability, and of LB-102 versus…
Cannabis use disorder is a frequent comorbidity of schizophrenia, associated with increased symptoms and less adherence to therapy. Validated care has limited e…
This study will consist of 2 parts: Part Ⅰ-in healthy adult subjects, Part Ⅱ-in adult patients with schizophrenia
This is a double blind adjunctive randomized controlled trial for schizophrenia using acetazolamide.
The purpose of this study is to determine if taking a synbiotic supplement versus a placebo will reduce symptoms of schizophrenia when used in addition to stand…
Phase 3, open label, multicenter study designed to assess the long term safety and tolerability of LB-102 for the treatment of adult patients with stable schizo…
The combination of pharmacotherapy and individual cognitive behavioral therapy in a private practice.